Clinical Trial Update: Randomized Study of ABC-14 Regimen Compared With "3+7" Standard Induction Therapy or AB-14 for ND AML [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 randomized study comparing the ABC-14 regimen with the 3+7 induction therapy or AB-14 for newly diagnosed acute m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• "3+7" standard induction therapy
• AB-14 regimen
• ABC-14 regimen
• CYTARABINE (CYTARABINE)
• Daunorubicin (daunorubicin)

Snippet

Sponsor: Guangdong Provincial People's Hospital | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: RECRUITING